The strong and muscle-specific staining of CA3, MYL3, and TNNT3 in healthy tissue indicates that detection of increased levels of these targets in blood samples of muscular dystrophy patients originates from the muscle, as these targets are not expressed in other tissues. Here, TNNT3 is linked to muscular dystrophy.